BioLife Solutions Updates 2025 Revenue Guidance to $100-103mln, Reflecting 22-25% YoY Growth

BioLife Solutions, Inc. revised its earnings guidance for 2025, expecting revenue to be between $100.0 million and $103.0 million, a 22% to 25% increase from 2024. The guidance reflects a year-over-year growth of 24% to 26% for the Cell Processing platform revenue and a year-over-year growth of 3% to 15% for evo and Thaw platform revenue.

BioLife Solutions, Inc. (Nasdaq: BLFS) has revised its financial projections for 2025, forecasting revenue to range between $100.0 million and $103.0 million. This represents a 22% to 25% increase from the prior year, with a focus on growth across its Cell Processing and evo and Thaw platforms. The company expects cell processing revenue to grow by 24% to 26%, while evo and Thaw platform revenue is anticipated to increase by 3% to 15% [1].

The revised guidance reflects strong performance in the second quarter of 2025, where cell processing revenue reached $23.0 million, up 28% year-over-year. This growth was driven by the company's biopreservation media (BPM) franchise, which saw continued strength across both direct and distributor channels. The company's media is embedded in 16 approved therapies and supports over 250 ongoing commercial trials, including over 30 in Phase III [1].

BioLife Solutions also reported a GAAP gross margin of 62% and a non-GAAP adjusted gross margin of 65% for the second quarter. The company expects gross margins to remain in the low 60% range (GAAP) and mid-60% range (non-GAAP) for the full year 2025. Additionally, the company aims to reduce its net loss and expand adjusted EBITDA margin compared to 2024 [1].

The company's earnings call and webcast are scheduled for today at 4:30 p.m. ET (1:30 p.m. PT). Investors can access the webcast via the BioLife Solutions Investor Relations page or by dialing toll-free 1-833-630-0431 or 1-412-317-1808 for international callers [1].

References:
[1] https://www.prnewswire.com/news-releases/biolife-solutions-reports-second-quarter-2025-financial-results-302524721.html